Log In Sign up
The largest database of trusted experimental protocols

Avance 600 mhz spectrometer

Manufactured by Chenomx
Visit Supplier

The Avance-600 MHz Spectrometer is a high-performance nuclear magnetic resonance (NMR) instrument manufactured by Bruker. It operates at a frequency of 600 MHz, which allows for the precise analysis of molecular structures and compositions. The spectrometer is designed to deliver reliable and accurate results in a wide range of applications, including chemical analysis, material science, and biomedical research.

Automatically generated - may contain errors

Lab products found in correlation

Nmr suite software, by Chenomx (3 mentions)

3 protocols using avance 600 mhz spectrometer

1

Quantifying Short-Chain Fatty Acids

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 48

Short-chain fatty acids (SCFA), which are produced by many bacteria as a byproduct of carbohydrate fermentation. SCFA have been found to be important modulators of the immune system. They are abundantly produced bacteria from the Class Clostridia. To evaluate the effect of administered bacterial composition, optionally with one or more prebiotics, on SCFA, fecal pellets are collected to quantify SCFA levels, particularly acetate, propionate, or butyrate. SCFAs, creatines, and hydroxy-SCFAs are quantified by alkalinizing stool samples, obtaining fingerprints of the metabolic composition of the sample using 1D 1H NMR on a Bruker Avance-600 MHz Spectrometer, and analyzing with supervised multivariate statistical methods using Chenomx NMR Suite software.

US11672834B2. Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome (2023-06-13). Evelo Biosciences, Inc. [US]. Inventors: David Berry [US], Noubar B. Afeyan [US], Johanne Kaplan [US], Shaila Rahman [US].
+ Open protocol
+ Expand
2

Metabolic Profiling of Gut Microbiome

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 48

Short-chain fatty acids (SCFA), which are produced by many bacteria as a byproduct of carbohydrate fermentation. SCFA have been found to be important modulators of the immune system. They are abundantly produced bacteria from the Class Clostridia. To evaluate the effect of administered bacterial composition, optionally with one or more prebiotics, on SCFA, fecal pellets are collected to quantify SCFA levels, particularly acetate, propionate, or butyrate. SCFAs, creatines, and hydroxy-SCFAs are quantified by alkalinizing stool samples, obtaining fingerprints of the metabolic composition of the sample using 1D 1H NMR on a Bruker Avance-600 MHz Spectrometer, and analyzing with supervised multivariate statistical methods using Chenomx NMR Suite software.

US10980845B2. Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome (2021-04-20). Evelo Biosciences, Inc. [US]. Inventors: David Berry [US], Noubar B. Afeyan [US], Johanne Kaplan [US], Shaila Rahman [US].
+ Open protocol
+ Expand
3

Profiling Gut Microbiome SCFA Production

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 48

Short-chain fatty acids (SCFA), which are produced by many bacteria as a byproduct of carbohydrate fermentation. SCFA have been found to be important modulators of the immune system. They are abundantly produced bacteria from the Class Clostridia. To evaluate the effect of administered bacterial composition, optionally with one or more prebiotics, on SCFA, fecal pellets are collected to quantify SCFA levels, particularly acetate, propionate, or butyrate. SCFAs, creatines, and hydroxy-SCFAs are quantified by alkalinizing stool samples, obtaining fingerprints of the metabolic composition of the sample using 1D 1H NMR on a Bruker Avance-600 MHz Spectrometer, and analyzing with supervised multivariate statistical methods using Chenomx NMR Suite software.

US10869903B2. Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease (2020-12-22). Evelo Biosciences, Inc. [US]. Inventors: David Berry [US], Noubar B. Afeyan [US], Johanne Kaplan [US], Neal Gordon [US], Shaila Rahman [US].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!